Linearis Ventures

Feldan Therapeutics specializes in intracellular drug delivery using its patented Feldan Shuttle technology. This platform enables rapid, safe, and efficient transport of therapeutic agents into cells, with a focus on developing treatments for serious diseases such as skin and lung conditions.

Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

Zilia is a medtech company developing a non-invasive platform that uses imaging, spectroscopy and artificial intelligence to quantify biomarkers in the eye. The technology leverages the eye’s optical properties and its link to the vascular system and brain to enable early detection and monitoring of ocular and systemic health conditions. Its first product, Zilia Ocular, is a retinal camera designed to quantify oxygen saturation, a key biomarker in diseases such as glaucoma, diabetic retinopathy and age-related macular degeneration. By delivering actionable data on the eye’s metabolic activity, Zilia aims to improve prevention, diagnosis and management of these conditions.